1. SP002CLINICAL OUTCOMES WITH MIGALASTAT IN PATIENTS WITH FABRY DISEASE BASED ON DEGREE OF RENAL IMPAIRMENT: RESULTS FROM PHASE 3 TRIALS. (18th May 2018) Authors: Torra, Roser; Germain, Dominique; Bichet, Daniel; Schiffmann, Raphael; Yu, Julie; Castelli, Jeffrey; Skuban, Nina; Barth, Jay Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SP004EFFECTS OF LONG-TERM MIGALASTAT TREATMENT ON RENAL FUNCTION BY BASELINE PROTEINURIA IN PATIENTS (PTS) WITH FABRY DISEASE. (18th May 2018) Authors: Schiffmann, Raphael; Bichet, Daniel; Germain, Dominique; Giugliani, Roberto; Hughes, Derralynn; Nicholls, Kathleen; Wilcox, William; Williams, Hadis; Yu, Julie; Castelli, Jeffrey; Skuban, Nina; Barth, Jay Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. (2019) Authors: Bichet, Daniel; Bouvier, Michel; Chin, Bice Journal: IUPHAR/BPS guide to pharmacology CITE Issue: Number 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Vasopressin and oxytocin receptors in GtoPdb v.2023.1. (2023) Authors: Bichet, Daniel; Bouvier, Michel; Chini, Bice Journal: IUPHAR/BPS guide to pharmacology CITE Issue: Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗